Growth Metrics

Mannkind (MNKD) Shares Outstanding (Diluted Average) (2020 - 2026)

Mannkind (MNKD) reported Shares Outstanding (Diluted Average) of $308.3 million for Q1 2026, down 3.94% year-over-year from $320.9 million in Q1 2025, and down 1.86% on a QoQ basis from $314.1 million in Q4 2025.

Mannkind (MNKD) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $308.3 million in Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) fell 3.94% year-over-year to $308.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $308.3 million (down 3.94% YoY) and the FY2025 annual result came in at $314.1 million, up 10.66% from the prior year.
  • Shares Outstanding (Diluted Average) declined to $308.3 million in Q1 2026 per MNKD's latest filing, from $314.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $324.7 million in Q1 2024 and bottomed at $251.9 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $281.4 million (2024), against an average of $287.0 million.
  • The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) advanced 24.86%; it then dropped 13.08% in 2024.
  • Tracing MNKD's Shares Outstanding (Diluted Average) over 5 years: stood at $257.1 million in 2022, then increased by 3.86% to $267.0 million in 2023, then climbed by 6.3% to $283.8 million in 2024, then advanced by 10.66% to $314.1 million in 2025, then slipped by 1.86% to $308.3 million in 2026.
  • Per Business Quant, the three latest MNKD Shares Outstanding (Diluted Average) figures stand at $308.3 million (Q1 2026), $314.1 million (Q4 2025), and $313.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 308.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 308.27 Mn
Dec 31, 2025 314.11 Mn
Sep 30, 2025 313.34 Mn
Jun 30, 2025 312.38 Mn
Mar 31, 2025 320.90 Mn
Dec 31, 2024 283.84 Mn
Sep 30, 2024 281.41 Mn
Jun 30, 2024 279.36 Mn
Mar 31, 2024 324.73 Mn
Dec 31, 2023 267.01 Mn
Sep 30, 2023 323.77 Mn
Jun 30, 2023 264.80 Mn
Mar 31, 2023 263.97 Mn
Dec 31, 2022 257.09 Mn
Sep 30, 2022 259.30 Mn
Jun 30, 2022 253.64 Mn
Mar 31, 2022 251.89 Mn
Dec 31, 2021 249.24 Mn
Sep 30, 2021 248.62 Mn
Jun 30, 2021 247.97 Mn
Dec 31, 2020 222.59 Mn